Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres
- 1 January 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 43 (1), 65-74
- https://doi.org/10.1016/s0168-3659(96)01471-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cytokine regulation of T-cell function: potential for therapeutic interventionImmunology Today, 1993
- Lysis of human pancreatic adenocarcinoma cells by autologous hla‐class I‐restricted cytolytic T‐lymphocyte (CTL) clonesInternational Journal of Cancer, 1993
- Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In VitroJournal of Cellular Physiology, 1992
- The controlled release of blue dextran from alginate beadsInternational Journal of Pharmaceutics, 1992
- Controlled and modulated release of basic fibroblast growth factorBiomaterials, 1991
- Controlled Release of Interleukin-2 from Biodegradable MicrospheresNature Biotechnology, 1990
- Characterization of Albumin-Alginic Acid Complex CoacervationJournal of Pharmacy and Pharmacology, 1989
- Chitosan‐Alginate Complex Coacervate Capsules: Effects of Calcium Chloride, Plasticizers, and Polyelectrolytes on Mechanical StabilityBiotechnology Progress, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985